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	 Two	 methods,	 a	 reversed	 phase	 high‐performance	 liquid	 chromatographic	 (RP‐HPLC)
method	and	a	direct	ultra‐violet	spectrophotometric	method,	were	adopted	and	validated	for
the	quantification	of	sofosbuvir,	which	is	a	new	antiviral	agent	used	for	treatment	of	patients
with	 hepatitis	 C	 virus	 (HCV).	 Validation	 parameters	 such	 as	 linearity,	 accuracy,	 precision,
specificity,	 limits	 of	 detection	 and	 quantification	 were	 determined	 according	 to	 the
guidelines	of	 International	Conference	on	Harmonization	 (ICH)‐Q2B.	The	RP‐HPLC	method
was	applied	on	HypersilTM	ODS	C18	column	(150×4.6	mm,	5	µm)	as	a	stationary	phase.	The
mobile	phase	was	optimized	according	to	the	polarity	of	the	studied	drug.	It	was	methanol:
acetonitrile	(90:10,	v:v),	pumped	using	an	isocratic	mode	with	flow	rate	of	1	mL/min	and	UV
detection	 at	 260	 nm.	 The	 UV	 spectrophotometric	 method	 was	 performed	 for	 the	 studied
drug	 at	 260	nm.	The	 calibration	 curves	were	 linear	 in	 the	 ranges	 of	 2‐60	µg/mL	and	 5‐40
µg/mL	 for	 the	 RP‐HPLC	 and	 UV	 spectrophotometric	 methods,	 respectively.	 The	 proposed
methods	 are	 accurate,	 sensitive	 and	 precise,	 so	 they	 can	 be	 successfully	 adopted	 for	 the
reliable	determination	of	sofosbuvir	content	in	its	tablet	form.	
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1.	Introduction	
	
Sofosbuvir	 (SFV)	 (isopropyl	 (2S)‐2‐[[[(2R,3R,4R,5R)‐5‐(2,	
4‐dioxopyrimidin‐1‐yl)‐4‐fluoro‐3‐hydroxy‐4‐methyl‐tetra	
hydrofuran‐2‐yl]	 methoxy‐phenoxy‐phosphoryl]	 amino]	 pro‐
panoate)	 is	 a	nucleotide	prodrug	analog	 that	 can	be	used	 for	
treatment	of	patients	with	hepatitis	C	virus	(HCV)	(Scheme	1)	
[1].	 It	 can	 be	 metabolized	 to	 the	 pharmacologically	 active	
uridine	 analog	 triphosphate.	 This	 metabolite	 can	 be	
incorporated	into	the	ribonucleic	acid	(RNA)	of	the	HCV	and	so	
acts	as	a	 chain	 terminator.	The	 termination	of	RNA	synthesis	
prevents	 replication	 of	 the	 virus	 and	 so	 leads	 to	 a	 rapid	
decrease	 of	HCV	viral	 count	 [2].	 SFV	 can	be	used	 alone	or	 in	
combination	with	other	drugs	like	ribavarin	and	ledipasvir	[3].	
SFV	has	been	included	in	the	essential	medicines	list	of	World	
Health	Organization	(WHO)	which	shows	the	high	potentiality	
of	the	drug	in	the	treatment	regimen	of	HCV	[4].	
There	 is	 no	 much	 reported	 literature	 concerning	 the	
quantification	of	 SFV	due	 to	 the	 recent	 launch	of	 the	drug	 in	
the	market	(2013).	All	the	performed	methods	used	the	ultra‐
performance	 liquid	chromatography	 ‐	 tandem	mass	spectros‐
copy	 (UPLC‐MS/MS)	 technique	 for	 the	 studied	 drug	 deter‐
mination	with	other	antiviral	drugs	like	ribavirin,	ledipasvir	or	
with	its	metabolite	[5‐7].	
	
 
	
	
Scheme	1	
		
From	 the	 previous	 literature	 review,	 there	 is	 an	 urgent	
need	 for	 a	 simple,	 accurate	 and	 economic	 analytical	 method	
for	the	rapid	quantification	of	SFV	either	in	pure	form	or	in	its	
tablet	 form	 as	 all	 the	 published	methods	 used	 a	 complicated	
expensive	technique	(UPLC‐MS/MS).	The	target	of	the	present	
work	is	to	apply	and	validate	analytical	methods	characterized	
with	 accuracy	 and	 simplicity	 like	 RP‐HPLC	 and	 UV	 spectro‐
photometry	for	the	quantification	of	the	studied	drug	either	in	
pure	 or	 in	 dosage	 forms	 and	 can	 be	 applied	 for	 the	 rapid	
estimation	of	SFV	in	quality	control	laboratories.	
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2.	Experimental	
	
2.1.	Chemicals	and	reagents	
	
Pure	 sofosbuvir	 (PSI‐7977)	was	 purchased	 from	 Cayman	
Chemical	 Company,	 Ann	 Arbor,	 United	 States	 of	 America	
(USA);	 its	 purity	 was	 certified	 to	 be	 99.9%.	 Acetonitrile	 and	
methanol	 (HPLC	 grade)	 were	 supplied	 by	 Sigma	 Aldrich,	 St.	
Louis,	USA.		
	
2.2.	Pharmaceutical	formulation	
	
Sovaldi®	 400	mg	 film	 coated	 tablets	 with	 batch	 number	
PMPW.	 It	 was	 manufactured	 by	 Gilead	 Sciences,	 Inc.	 Foster	
City,	USA.	
	
2.3.	Instrumentation	
	
The	 liquid	 chromatographic	 method	 was	 performed	 on	
high	performance	liquid	chromatograph	consisted	of	a	binary	
pump	 (Waters,	 1525),	 a	 UV‐visible	 wavelength	 detector	
(Waters,	 2489)	 and	 an	 auto‐sampler	 (Waters,	 2707).	 The	
chromatograph	 is	 a	 product	 of	 Waters,	 Massachusetts,	 USA.	
The	spectrophotometric	analysis	was	done	using	double	beam	
spectrophotometer	 (JASCO,	 Japan)	 with	 1	 cm	 path	 length	
matched	 quartz	 cuvettes.	 It	 is	 connected	 to	 IBM	 compatible	
computer	with	HP	680	inkjet	printer	(Hewlett	Packard,	USA).		
	
2.4.	Standard	solutions	
	
Stock	 standard	 solution	 (1	 mg/mL)	 was	 prepared	 by	
accurate	weighing	and	transferring	of	50	mg	of	pure	SFV	into	
50	 mL	 measuring	 flask.	 The	 drug	 was	 dissolved	 by	 aid	 of	 a	
vortex	 mixer	 in	 20	 mL	 methanol	 then	 the	 volume	 was	
completed	 to	 the	 mark	 using	 the	 same	 solvent.	 Working	
standard	 solution	 (100	 µg/mL)	 was	 prepared	 by	 accurate	
dilution	of	5	mL	of	the	stock	standard	solution	(1	mg/mL)	into	
50	mL	measuring	flask	using	methanol	as	a	diluting	solvent.	
	
2.5.	Method	validation	
	
The	 developed	 analytical	 methods	 were	 fully	 validated	
according	to	ICH‐Q2B	guidelines	[8].	
	
2.5.1.	Linearity		
	
2.5.1.1.	HPLC‐method	
	
Aliquots	 (0.2‐6.0	 mL)	 of	 SFV	 working	 standard	 solution	
(100	µg/mL)	were	accurately	and	separately	transferred	into	a	
series	 of	 10	 mL	 measuring	 flasks,	 the	 volume	 was	 then	
completed	with	methanol	to	obtain	a	concentration	range	of	2‐
60	µg/mL.	The	prepared	samples	were	filtered	through	a	0.45	
µm	membrane	filter	then	injection	was	carried	out	by	the	aid	
of	a	50	µL	Hamilton®	syringe.	Conditioning	and	pre‐washing	of	
the	 stationary	 phase	was	 performed	 by	 passing	 about	 60‐70	
mL	of	the	mobile	phase.	
Samples	 were	 then	 chromatographed	 using	 HypersilTM	
ODS	C18	 column	 (250×4.6	mm,	 5	 µm)	 as	 a	 stationary	 phase.	
The	 mobile	 phase	 was	 methanol:	 acetonitrile	 (90:10,	 v:v).	 It	
was	pumped	using	isocratic	mode	with	flow	rate	of	1	mL/min	
and	 UV	 detection	 at	 260	 nm.	 Peak	 area	 ratios	 were	 plotted	
against	concentration	to	obtain	the	calibration	graph	then	the	
regression	equation	was	computed.		
	
2.5.1.2.	UV‐spectrophotometric	method	
	
Aliquots	 (0.5‐4.0	 mL)	 of	 SFV	 working	 standard	 solution	
(100	µg/mL)	were	transferred,	accurately	and	separately,	into	
a	 series	 of	 10	 mL	 measuring	 flasks	 then	 the	 volume	 was	
completed	with	methanol	to	obtain	a	concentration	range	of	5‐
40	 µg/mL.	 The	 absorption	 spectrum	 of	 each	 solution	 was	
scanned	using	methanol	as	a	blank.	Absorbance	at	max	=	260	
nm	 was	 recorded	 for	 each	 concentration.	 The	 calibration	
graph	 was	 plotted	 between	 absorbance	 and	 concentration	
then	the	regression	equation	was	computed.	
	
2.5.2.	Accuracy	
	
Accuracy	 can	 be	 defined	 as	 the	 percent	 of	 the	 recovered	
analyte	 from	 a	 known	 added	 quantity	 [9].	 Data	 from	 nine	
samples	 representing	 three	 concentration	 levels	 covering	 the	
obtained	 linearity	 range	 (10,	 30	 and	 50	 µg/mL	 for	 the	HPLC	
method	 and	 10,	 20	 and	 30	 µg/mL	 for	 the	 UV‐spectrophoto‐
metric	method)	was	used	to	assess	accuracy	of	both	methods,	
so	the	previously	mentioned	procedures	under	linearity	were	
carried	 out	 then	 the	 concentration	 of	 SFV	 samples	 was	
calculated	using	the	corresponding	regression	equation.	
	
2.5.3.	Precision	
	
Precision	 can	 be	 defied	 as	 the	 degree	 of	 repeatability	
under	normal	operational	conditions.	The	assay	precision	can	
be	 determined	 by	 repeatability	 (intra‐day)	 and	 intermediate	
precision	 (inter‐day)	 then	 reported	 as	 %	 relative	 standard	
deviation	 (%R.S.D.),	 for	 a	 number	 of	 experiments	 which	 are	
statistically	significant	[10]	so	three	concentrations	of	SFV	(10,	
30	 and	 50	 µg/mL	 for	 the	 HPLC	 method	 and	 10,	 20	 and	 30	
µg/mL	for	the	UV‐spectrophotometric	method)	were	analyzed	
three	 times	 within	 the	 same	 day	 (intra‐day)	 or	 on	 three	
successive	days	(inter‐day)	then	the	results	were	documented	
as	%R.S.D.	
	
2.5.4.	Specificity	
	
Specificity	 can	 be	 determined	 by	 comparing	 the	 HPL	
chromatogram	and	the	UV‐scan	obtained	for	a	mixture	of	SFV	
and	 the	commonly	used	excipients,	with	 those	obtained	 from	
the	blank	(excipients	solution	in	methanol	without	drug)	[10].	
The	 chosen	 excipients	were	microcrystalline	 cellulose,	 colloi‐
dal	 silicon	 dioxide,	 mannitol,	 croscarmellose	 sodium,	 and	
magnesium	stearate.	These	 inactive	 ingredients	were	used	 in	
the	 manufacture	 of	 Sovaldi®	 400	mg	 film	 coated	 tablets	 as	
mentioned	 in	 its	monograph.	The	drug	 to	excipient	ratio	was	
similar	to	that	used	in	the	market	product.	
	
2.5.5.	Limits	of	detection	and	quantification	
	
Limits	 of	 detection	 (LOD)	 can	 be	 defined	 as	 the	 lowest	
concentration	 of	 the	 analyte	 that	 the	 analytical	 method	 can	
reliably	differentiate	from	the	background.	Limits	of	quantify‐
cation	 (LOQ)	can	be	defined	as	 the	 lowest	concentration	 that	
can	be	quantified	with	acceptable	accuracy	and	precision	[10].	
The	LOD	and	LOQ	were	calculated	as	
	
LOD	=	3.3	σ	/	S	 	 	 	 	 (1)	
	
LOQ	=	10	σ	/	S	 	 	 	 	 (2)	
	
where,	σ	is	the	standard	deviation	of	the	lowest	standard	level	
and	S	is	the	slope	of	the	standard	curve.	
	
2.5.6.	Robustness	
	
Robustness	 was	 assessed	 by	 evaluating	 the	 effect	 of	
minute	 variations	 on	 the	 proposed	 methods.	 The	 conditions	
studied,	for	the	HPLC‐method,	were	the	flow	rate	variation	by	
0.1	 mL/min	 and	 mobile	 phase	 composition	 with	 respect	 to	
methanol	±5	mL	per	each	100	mL	of	the	mobile	phase.	On	the	
other	 hand,	 for	 the	 spectrophotometric	 method	 the	 solvent	
composition	was	slightly	changed	by	adding	1%	acetonitrile.	
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Figure	1.	An	HPL	chromatogram	of	20	µg/mL	sofosbuvir.	
	
	
	
	
Figure	2.	Absorption	spectrum	of	10	µg/mL	sofosbuvir	using	methanol	as	blank.
	
	
2.5.7.	System	suitability	
	
The	 system	 suitability	 for	 the	 chromatographic	 method	 was	
evaluated	 according	 to	 tailing	 factor,	 number	 of	 theoretical	
plates	(N)	and	height	equivalent	to	theoretical	plates	(HETP).	
	
2.6.	Analysis	of	pharmaceutical	formulation	
	
Ten	Sovaldi®	400	mg	film	coated	 tablets	were	weighed	 to	
find	 the	 average	 weight	 of	 a	 tablet	 then	 crushed,	 finely	
powdered	and	mixed	well.	Tablet	powder	equivalent	to	10	mg	
of	SFV	was	transferred	to	a	beaker	of	250	mL	capacity	then;	a	
suitable	 volume	 of	methanol	 (40	mL)	was	 added	 and	 stirred	
for	about	20	minutes.	Filtration	was	carried	out	 into	100	mL	
measuring	 flask.	 The	 residue	was	washed	with	 about	 20	mL	
methanol	 (twice),	and	 then	 the	volume	was	completed	to	 the	
mark	with	methanol	and	mixed	well.	The	general	procedures	
were	 followed	 as	 mentioned	 under	 linearity	 for	 both	
techniques	 then	 the	 concentration	 of	 SFV	was	 obtained	 from	
the	corresponding	regression	equation.	
Moreover,	 standard	 addition	 procedure	 was	 applied	 by	
spiking	 different	 known	 quantities	 of	 pure	 SFV	 to	 the	 tablet	
formulation,	 and	 then	 the	 procedures	 were	 followed	 as	
mentioned	before.	
	
3.	Results	and	discussion		
	
Two	 simple	 analytical	 methods	 were	 developed	 for	 the	
quantification	 of	 SFV	 either	 in	 pure	 or	 tablet	 forms.	 These	
methods	can	 be	 conveniently	 applied	 for	 the	 routine	 quality	
control	 analysis	 of	 pharmaceutical	 dosage	 forms.	 Both	
methods	 were	 developed	 and	 validated	 according	 to	 the	
guidelines	of	ICH‐Q2B	[8].		
The	 first	 one	 is	 an	 isocratic	 reversed	 phase	 high‐
performance	 liquid	 chromatographic	 (RP‐HPLC)	method.	The	
parameters	were	optimized	to	get	an	optimum	performance	of	
the	method.	The	mobile	phase	selection	was	done	depending	
on	 the	 polarity	 of	 the	 studied	 drug.	 Different	 stationary	 and	
mobile	phases	were	 tried	 to	 reach	 the	best	match	and	so	get	
the	 best	 separation	 pattern	 of	 SFV.	 The	 best	 Gaussian	 peak	
with	 ideal	 peak	 symmetry	was	 obtained	 on	 using	HypersilTM	
ODS	 C18	 column	 (150×4.6	mm,	 5	 µm)	 as	 a	 stationary	 phase	
and	methanol:acetonitrile	 (90:10,	v:v)	as	a	mobile	phase.	The	
mobile	phase	flow	was	operated	using	the	isocratic	mode	with	
a	rate	of	1	mL/min	and	UV	detection	at	260	nm.	By	adopting	
the	 described	 chromatographic	 conditions,	 SFV	 was	 well	
separated	 with	 average	 retention	 time	 of	 1.99±0.05	 min	 as	
shown	in	Figure	1.	
On	 the	 other	hand,	 the	 second	method	was	based	on	 the	
absorption	 power	 of	 SFV	 in	 the	 ultra	 violet	 (UV)	 region.	 SFV	
has	 specific	 structural	 arrangement	 that	 absorb	UV	 rays	 at	 a	
specific	 wavelength	 (260	 nm)	 and	 this	 information	 was	
successfully	used	for	its	determination,	Figure	2.	
	
3.1.	Method	validation	
	
3.1.1.	Linearity	
	
3.1.1.1.	HPLC‐method	
	
Calibration	 standards	 at	 seven	 levels	 were	 prepared	 by	
suitable	dilution	of	the	working	standard	solution	of	SFV	(100	
µg/mL)	 to	 reach	 concentration	 range	 of	 2‐60	 µg/mL.	 Each	
concentration	was	 injected	 in	 triplicate,	 and	peak	 area	 ratios	
were	 plotted	 against	 the	 corresponding	 concentrations	 to	
obtain	the	calibration	curve	then	the	regression	equation	was	
computed	to	be:	
	
P	=	0.0337	×	C	+	0.0091	(r2	=	0.9996)	 	 	 (3)	
	
where,	 P	 is	 the	peak	 area	 ratio	 and	C	 is	 the	 concentration	 in	
µg/mL.		
	
3.1.1.2.	Spectrophotometric	method	
	
Five	concentration	levels	were	prepared	from	the	working	
standard	 solution	 of	 SFV	 (100	 µg/mL)	 in	 the	 range	 5‐40	
µg/mL.	A	linear	correlation	was	obtained	between	absorbance	
at	260	nm	and	the	corresponding	concentration	of	the	studied	
drug.		
The	following	regression	equation	was	computed	to	be:	
	
A	=	0.029	×	C	–	0.0073	(r2	=	0.9997)	 	 	 (4)	
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Table	1.	Method	validation	parameters	for	determination	of	sofosbuvir	by	the	adopted	methods.	
Parameter	 Method
HPLC UV	Spectrophotometry	
Linearity	
		Range,	µg/mL	 2‐60	 5‐40
		Slope	 0.0337 0.029
		Intercept	 0.0091	 ‐0.0073	
		r2	 0.9996	 0.9997	
Accuracy	
		Mean±S.D.	a	 98.94±0.899 100.96±0.745
		Variance	 0.808 0.555
		%R.S.D.	 0.909 0.738
Precision	
		Intraday	precision,	%	 99.81±1.121 100.94±0.874
		Interday	precision,	%	 98.59±1.412 101.84±1.028
Robustness	 0.657	b	 0.691	
0.574	c
LOD,	µg/mL	 0.25	 1.50
LOQ,	µg/mL	 1.70	 4.50	
a	Standard	deviation,	average	of	three	determinations.		
b	Variation	of	flow	rate.	
c	Variation	of	mobile	phase	composition.		
	
Table	2.	Established	system	suitability	parameters	for	the	HPLC	method.	
Parameter	 SFV	peak Significance
tR	(min)	*	 1.99±0.05 ‐
Tailing	factor	 1.1 T	=	1	for a	typical	symmetric	peak	
Number	of	theoretical	plates	(N)	 253 Increase	with	the	increase	in	column	efficiency
Height	equivalent	to	theoretical	plate	(HETP)	 0.099 Decrease	with	the	increase	in	column	efficiency
*	Average	of	triplicate	runs.	
	
Table	3.	Determination	of	sofosbuvir	in	Sovaldi®	400	mg	film	coated	tablets	and	application	of	standard	addition	procedure	by	the	proposed	methods.	
Method	 Content	uniformity Standard	addition
Mean±S.D.	*	 %	R.S.D.	 Mean±S.D.	*	 %	R.S.D.	
HPLC	method	 102.08±0.974 0.954 101.74±0.786 0.773	
UV	spectrophotometric	method	 98.96±0.842	 0.851 99.74±0.652 0.654	
*	Average	of	three	determinations.	
	
where,	 A	 is	 the	 absorbance	 at	 260	 nm	 and	 C	 is	 the	 concent‐
ration	in	µg/mL.		
	
3.1.2.	Accuracy	
	
The	 accuracy	 of	 the	 proposed	methods	was	 validated	 by	
analyzing	 nine	 quality	 control	 samples	 of	 SFV	 representing	
three	 concentration	 levels	 covering	 the	 specified	 linearity	
range	 then	 calculating	 the	 recovery	 and	 percent	 of	 relative	
standard	deviation	(%	R.S.D.)	which	is	considered	satisfactory	
as	 it	 was	 less	 than	 1%	 for	 both	methods	 which	 confirm	 the	
accuracy	of	the	developed	methods	(Table	1).	
	
3.1.3.	Precision	
	
The	 intraday	 and	 interday	 precisions	 were	 checked	 by	
analyzing	 three	 different	 concentrations	 of	 SFV	 by	 adopting	
the	proposed	methods,	either	in	the	same	day	or	during	three	
successive	days.	The	%	R.S.D.	values	for	intraday	and	interday	
precisions	were	less	than	2%	for	the	proposed	methods,	which	
confirm	the	good	precision	of	both	methods	(Table	1).	
	
3.1.4.	Specificity	
	
The	proposed	methods	were	specific	as	none	of	 the	 tried	
excipients	interfered	with	the	drug	of	interest,	so,	the	methods	
were	suitably	applied	for	assaying	the	commercial	product.	
	
3.1.5.	Limits	of	detection	and	quantification	
	
The	 obtained	 values	 of	 LOD	 and	 LOQ	 confirmed	 the	
sufficient	sensitivity	of	the	proposed	methods	(Table	1).		
	
3.1.6.	Robustness	 	
	
It	 is	 a	 measure	 of	 the	 method	 capability	 to	 maintain	
unaffected	 by	 slight	 changes	 in	 its	 parameters.	 The	 studied	
parameters	 were	 the	 variation	 in	 flow	 rate	 or	 mobile	 phase	
composition	 (HPLC	 method)	 and	 solvent	 composition	
(spectrophotometric	 method).	 The	 proposed	 methods	 were	
not	affected	by	the	slight	changes	in	their	conditions	where	the	
%	 R.S.D.	 values	 were	 less	 than	 1%	 and	 so	 this	 confirms	 the	
robustness	of	the	methods	(Table	1).	
	
3.1.7.	System	suitability	
	
System	 suitability	 parameters	 for	 the	 chromatographic	
method	 were	 studied,	 to	 evaluate	 the	 peak	 symmetry	 and	
column	efficiency.	The	studied	parameters	were	tailing	factor,	
number	of	theoretical	plates	(N)	and	height	equivalent	to	theo‐
retical	 plates	 (HETP).	 The	 values	 of	 the	 studied	 parameters	
confirmed	 the	 excellent	 peak	 symmetry	 and	 high	 column	
efficiency,	Table	2.		
	
3.2.	Analysis	of	pharmaceutical	formulation	
	
The	proposed	methods	were	successfully	adopted	 for	 the	
quantification	of	SFV	in	Sovaldi®	400	mg	film	coated	tablets	to	
assess	 content	 uniformity	 (Table	 3).	 The	 commercial	 dosage	
form	showed	acceptable	recoveries	by	applying	the	proposed	
methods	which	showed	acceptable	 limits	of	content	uniform‐
mity.	 Also,	 the	 standard	 addition	 procedure	 was	 applied	 by	
spiking	 different	 known	 quantities	 of	 pure	 SFV	 to	 the	 tablet	
formulation	 to	 ensure	 the	 applicability	 and	 reliability	 of	 the	
proposed	methods.	The	results	showed	satisfactory	recoveries	
of	the	pure	added	drug	by	the	proposed	methods	(Table	3).		
	
4.	Conclusion	
	
The	 proposed	 RP‐HPLC	 and	 UV	 spectrophotometric	
methods	are	simple,	sensitive	and	selective	having	acceptable	
accuracy	and	precision.	Also,	 the	short	analysis	 time	 for	both	
methods	 makes	 them	 suitable	 for	 the	 assay	 of	 SFV	 in	 its	
commercial	 product	 during	 the	 routine	 analysis	 in	 quality	
control	 laboratories.	 Moreover,	 the	 UV‐spectrophotometric	
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method	 offers	 a	 cost	 effective	 alternative	 to	 the	 RP‐HPLC	
method	of	analysis.	
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